Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G O Broun

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer|August 1, 1984
T-cell prolymphocytic leukemia with helper-cell phenotype and a review of the literatureL M Tsai, C C Tsai, T P Hyde, et al.
Journal of Neuropathology and Experimental Neurology|March 1, 1981
Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeysJ S Nelson, C D Fitch, V W Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupB J Roth, D H Johnson, L H Einhorn, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer|August 1, 1984
T-cell prolymphocytic leukemia with helper-cell phenotype and a review of the literatureL M Tsai, C C Tsai, T P Hyde, et al.
Journal of Neuropathology and Experimental Neurology|March 1, 1981
Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeysJ S Nelson, C D Fitch, V W Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupB J Roth, D H Johnson, L H Einhorn, et al.
Pageof 3